Quantitative Assessment of Serum C - Reactive Protein Levels among Smokers and Non Smokers

Background: Recent progress in the comprehension of intricate tumor interactions has resulted in the identification of a link between inflammation and cancer. A high level of pro-inflammatory cytokines within the tumor microenvironment can stimulate angiogenesis, thereby promoting neoplastic proliferation. Serum C-reactive protein serves as a sensitive indicator of inflammation and could possess considerable prognostic significance as an early biomarker for cancer diagnosis. Aims and Objectives: To quantitatively measure serum C-reactive protein levels in both smokers and non-smokers, as well as to assess its role in cancer development. Materials and Methods: The study included a sample of 25 non-smokers and 25 smokers. All samples underwent C-reactive protein testing using immunoturbidimetry. The observations were analyzed statistically. Statistical analysis: The data was entered into the database management system of SPSS version 20.0. An independent t-test and Mann-Whitney U test were utilized to compare the C-reactive protein levels between two groups. For pairwise comparisons, Tukey's multiple post hoc procedure was employed. Results: The average C-reactive protein level in non-smokers was 55.24±12.0312, while in smokers, it was 55.88±11.76. In smokers, the C-reactive protein level was slightly higher compared to non-smokers. The comparison between non-smokers and smokers regarding C-reactive protein values showed statistical significance, with a p-value of ≤0.05. Conclusion: Our results indicate that the concentration of serum C-reactive protein was higher in smokers and is linked to an increased risk of developing oral cancer, potentially serving as a biomarker.

C reactive protein, Smokers, Non – smokers, Cancer

1. World Health Organization. WHO Report on the Global Tobacco Epidemic, 2008: The MPOWER Package. Geneva: World Health Organization; 2008. [Google Scholar] [Crossref]

2. Centers for Disease Control and Prevention. 2004 Surgeon General’s Report – The Health Consequences of Smoking. Atlanta, GA: Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2004. [Google Scholar] [Crossref]

3. Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends. Lancet. 2007; 370:765–73. [Google Scholar] [Crossref]

4. Casas JP, Shah T, Hingorani AD, et al. C-reactive protein and coronary heart disease: a critical review. J Intern Med. 2008; 264:295–314 [Google Scholar] [Crossref]

5. Smith SC, Jr, Milani RV, Arnett DK, et al. Atherosclerotic Vascular Disease Conference: Writing Group II: risk factors. Circulation. 2004;109:2613–6. [Google Scholar] [Crossref]

6. Siemes C, Visser LE, Coebergh JW, Splinter TA, Witteman JC, Uitterlinder AG, Holfman A , Pols HA, Stricker BH. C – reactive protein levels, variation in the C – reactive protein gene and cancer risk: the Rotterdam study. J Clin Oncol 2006; 24:5216-5222 [Google Scholar] [Crossref]

7. Coussens LM, and Web Z. Inflammation and cancer. Nature 2002; 420:860-867. [Google Scholar] [Crossref]

8. Baron JA. Epidemiology of non – steroid inflammatory drugs and cancer. Prog Exp Tumor Res 2003; 37:1-24. [Google Scholar] [Crossref]

9. Baron JA. Epidemiology of non – steroid inflammatory drugs and cancer. Prog Exp Tumor Res 2003; 37:1-24. [Google Scholar] [Crossref]

10. Ockene IS, Miller NH. Cigarette smoking, cardiovascular disease, and stroke: a statement for healthcare professionals from the American Heart Association. American Heart Association Task Force on Risk Reduction. Circulation. 1997; 96:3243–7. [Google Scholar] [Crossref]

11. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med. 1999; 340:115–26. [Google Scholar] [Crossref]

12. Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends. Lancet. 2007 Sep 1;370(9589):765-73. [Google Scholar] [Crossref]

13. Majka DS, Holers VM. Cigarette smoking and the risk of systemic lupus erythematosus and rheumatoid arthritis. Ann Rheum Dis. 2006 May;65(5):561-3. [Google Scholar] [Crossref]

14. Lakatos PL, Szamosi T, Lakatos L. Smoking in inflammatory bowel diseases: good, bad or ugly? World J Gastroenterol. 2007 Dec 14;13(46):6134-9. [Google Scholar] [Crossref]

15. Baxi BR, Patel PS. A report on clinical importance of serum glycoconjugates in oral cancer. Indian J Biochem 1990; 5:139-44. [Google Scholar] [Crossref]

16. Black S, Kushner I, Samols D. C-reactive Protein. J Biol Chem. 2004 Nov 19;279(47):48487-90. [Google Scholar] [Crossref]

17. Wong ND, Pio J, Valencia R, Thakal G. Distribution of C-reactive protein and its relation to risk factors and coronary heart disease risk estimation in the National Health and Nutrition Examination Survey (NHANES) III. Prev Cardiol. 2001 Summer;4(3):109-114. [Google Scholar] [Crossref]

18. Zieske AW, Tracy RP, McMahan CA, et al. Elevated serum C-reactive protein levels and advanced atherosclerosis in youth. Arterioscler Thromb Vasc Biol. 2005; 25:1237–43. [Google Scholar] [Crossref]

• Extraction and Characterization of Eco-Friendly Hair Dye from Agricultural Waste: A Study on Coconut Husk
• Intermittent Preventive Treatment among Pregnant Women Attending a Tertiary Healthcare Facility in Jos, North Central Nigeria: Adherence Patterns and Preliminary Assessment of Associated Factors
• Assessment Of Degradative Potentials Of Bacteria Isolated From Palm Oil-Polluted Site Using Spectrophotometric Method